I am delighted to invite you to the 3rd annual diagnostic management team meeting. The 2019 meeting will be held in Galveston, Texas, at the Galveston Island Convention center on March 5 – 6. The focus of the upcoming meeting are the barriers that exist for the rapid and significant growth of diagnostic management teams to reduce medical error and optimize laboratory test use.
These barriers include communication and conductivity limitations, insufficient payment for consultation services by the DMT, an inadequate number of individuals able to lead a DMT, and the cultural barriers that prevent established laboratory directors from becoming DMT leaders.
We will feature 3 diagnostic management teams – microbiology, hematopathology, and platelet refractoriness. There are a number of other presentations, most noteworthy will be a presentation by a member of the public who is aware of the benefit of experts to other physicians. We will discuss with the audience how little patients know about not having expert input on their cases.
Poster presentations will be a part of the meeting. The meeting will close with a live webinar hosted by Roche diagnostics and moderated by Robert McGonnagle, editor of CAP today.
“The bottom line is that if you or a loved one is seriously ill with an unknown diagnosis, you want an expert in the field with current knowledge directing your diagnostic evaluation in real-time and explaining it all to you.” - Mike Laposata
Diagnostic Management Team (DMT) consultation services have been endorsed by the National Academy of Medicine, formerly the Institute of Medicine, in September, 2015, as a mechanism to reduce diagnostic error in the United States. This is a quantum leap forward for our patients and providers alike.
Those emerging from this one and a half day conference should have enough information to initiate an effective diagnostic management team, and will have had the opportunity to meet individuals who have faced barriers in DMT development and overcome them.
“I first learned about DMT when my mentor, Dr. Douglas Blackall recently shared with me that he had listened to a podcast on the subject. He is currently the Clinical Pathology Director of Cardinal Glennon Children's Hospital and the Transfusion Medicine Director of St. Louis University Hospital. He personally knows Dr. Laposata and couldn't stop speaking his praises as an educator as well as his reputation of fine quality and character.
Fast forward a few months later and our Chairperson, Dr. Carole Vogler, invited me to attend the DMT meeting. I jumped at the opportunity before the ink was left to dry. I am completing a fellowship in Transfusion Medicine and I have been offered the opportunity to stay at SLU. I will be covering the Transfusion Medicine service as well as general clinical pathology for both the adult and children's hospital with the hopes of expanding clinical consultative services.
I hope to bring back "actionable items" from this conference that will help me to improve and expand a niche within our department, especially ways I can improve the clinical consultation within transfusion medicine such as Pre-op anemia, PLT refractoriness and immunohematology consultations to name a few.”
Daniela Hermelin, MD